We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Last close (USD)5.05−0.20 (−3.81%)as of 4 Nov 2026
Funds that hold it1One fund per scheme
Held through a master fund10 buy the stock themselves
Largest weight in a single fund1.03%Of that fund's NAV
Median weight1.03%Half the funds hold more than this
What does PGEN do
Precigen, Inc.
Researches and develops gene therapies and immunotherapies for cancer and respiratory diseases. Still in drug development, with only small research revenue
PRGN-2012 (Papzimeos)Gene therapy platform
Which funds let you invest in PGEN
Sorted by weight held, largest first
Investors in Thailand can buy PGEN through 1 mutual funds open to retail investors. Most of them (1 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds PGEN.
Showing 1 of 1 funds you can buy · The full list is in the Expert view · Latest weights from portfolio reports, and funds can change their portfolios at any time · Past performance is not a guarantee of future performance
PGEN share price
0.00%
Price change over the selected periodN/A
50-day average
200-day average
Valuation and key ratios
Precigen, Inc. · NASDAQ · Fiscal year ends in January
Market cap1.8B USD0.36 billion shares
P/EN/AFY2025 EPS is negative
Forward P/E11.7xBased on forecast 12-month earnings
P/S22.3x
EV/EBITDA−3.3x
Dividend yield0.00%0.00 USD per share a year
ROE−843.6%Net profit ÷ shareholders' equity
Debt to equity (D/E)4.46xInterest-bearing debt
Beta0.96Against the S&P 500
Gross marginN/AFY2025
Operating margin−1,110.0%FY2025
Net margin−2,510.0%FY2025
Price ratios use the latest close shown on this page · Forward P/E, P/S and EV/EBITDA from Market data · Beta from 5 years of monthly returns · Total dividends over the last 12 months
Company health made simple
From the FY2025 statements
Sales growth−8.1%Slow growth
Yearly average over the last 4 years · Latest annual sales 10.0M USD
Profit from sales−2,510%Thin margin
For every 100 dollars of sales, about −2,510 dollars is left as net profit
Dividend0.00%No dividend
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
1-year share price+30.2%Up
Now 41.0% below its 1-year high
A rise or fall in the share price doesn't move a fund by the same amount — a fund is affected only in proportion to how much it holds
Financial statements
Revenue grows −8.1% a year on average · EPS grows N/A a year on average
Annual · last 5 fiscal years
Revenue and net profit
FY202114.0M USD−92.0M USD
FY202227.0M USD28.0M USD
FY20236.0M USD−96.0M USD
FY20244.0M USD−126.0M USD
FY202510.0M USD−251.0M USD
Total revenue
Net profit
Quarterly · last 5 quarters
Revenue and net profit
Q2 FY20232.0M USD−20.0M USD
Q1 FY20251.0M USD−54.0M USD
Q2 FY20251.0M USD−27.0M USD
Q1 FY202623.0M USD−8.0M USD
Q2 FY202655.0M USD20.0M USD
Total revenue
Net profit
Annual income statement, balance sheet and cash flow
Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
Total revenue
14.0M USD
27.0M USD
6.0M USD
4.0M USD
10.0M USD
Operating profit
N/A
N/A
−100.0M USD
−135.0M USD
−111.0M USD
Net profit
−92.0M USD
28.0M USD
−96.0M USD
−126.0M USD
−251.0M USD
EPS (diluted)
−0.23
0.07
−0.39
−0.47
−1.37
Operating margin
N/A
N/A
−1,666.7%
−3,375.0%
−1,110.0%
Net margin
−657.1%
103.7%
−1,600.0%
−3,150.0%
−2,510.0%
Operating cash flow
−56.0M USD
−65.0M USD
−67.0M USD
−68.0M USD
−88.0M USD
Free cash flow
−63.0M USD
−70.0M USD
−68.0M USD
−77.0M USD
−90.0M USD
Total assets
360.0M USD
216.0M USD
151.0M USD
145.0M USD
156.0M USD
Total liabilities
253.0M USD
90.0M USD
33.0M USD
79.0M USD
135.0M USD
Shareholders' equity
107.0M USD
126.0M USD
118.0M USD
66.0M USD
21.0M USD
Free cash flow = operating cash flow − capital expenditure · A cell showing N/A is an item the statement doesn't report, not a zero · Source: SEC EDGAR
Technical analysis
Closed at 5.05 USD on 4 Nov 2026
Daily trendClear downtrendScore −1.00 on a scale of −1 to +1 · 1254 bars
RSI(14)
32.2
ADX(14)
28.7
Position in the price range
0%
Weekly trendSidewaysScore −0.10 on a scale of −1 to +1 · 262 bars
RSI(14)
44.0
ADX(14)
35.4
Position in the price range
36%
Monthly trendClear uptrendScore 0.67 on a scale of −1 to +1 · 61 bars
RSI(14)
54.3
ADX(14)
44.4
Position in the price range
56%
Moving averages (daily)
Period
SMA
EMA
Price vs line
10 days
5.99
5.93
Below
20 days
6.57
6.39
Below
50 days
7.09
6.72
Below
100 days
6.49
6.37
Below
200 days
5.28
5.57
Below
Indicators (daily)
Indicator
Value
Signal
RSI(14)
32.17
Down
MACD(12,26)
−0.50
Down
ADX(14)
28.75
Neutral
ATR(14) % of price
6.48
Neutral
Support and resistance (weekly pivots)
s35
s26
s16
p7
r17
r28
r38
Trend score = average of the moving-average group and the indicator group ((up signals − down signals) ÷ number of signals) · RSI and ATR use Wilder's method · MACD uses the 12- and 26-period EMA · An ADX of 25 or above counts as a clear trend · Calculated from daily closing prices from Market data · Not investment advice
Thai funds holding PGEN
1 funds · Highest 1.03% · Median 1.03%
How the weights are spread
Number of funds by weight range
0
1
0
0
0
0
< 1%1–3%3–5%5–8%8–12%12%+
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
One fund counted per scheme · Funds investing through a master fund show the master fund's weight in PGEN, not the look-through weight · Past performance is not a guarantee of future performance
How Thai money reaches PGEN
1 master funds
Master fund
Thai funds using this route
Master fund's PGEN weight
First Trust Small Cap Growth AlphaDEX® Fund
1
1.03%
Data sourcesFunds that buy the stock themselves: top 5 holdings from the AMC's fact sheet as of 30 Sep 2026 · Funds that invest through a master fund: the master fund's portfolio from its issuer's fact sheet or prospectus · Each scheme counts as one fund · Share price: Market data · Financial statements: SEC EDGAR · Ratios: Market data · Weights are as of the report date, and funds can change their portfolios at any time · Investing involves risk. This is not investment advice.
DAOL-USSMALLDAOL US SMALL CAP FUND